News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
531,483 Results
Type
Article (31104)
Company Profile (90)
Press Release (500289)
Multimedia
Podcasts (30)
Webinars (9)
Section
Business (155503)
Career Advice (1041)
Deals (26598)
Drug Delivery (62)
Drug Development (61370)
Employer Resources (80)
FDA (13646)
Job Trends (11229)
News (261959)
Policy (23962)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1992)
Accelerated approval (4)
Adcomms (13)
Allergies (78)
Alliances (37907)
ALS (63)
Alzheimer's disease (1011)
Antibody-drug conjugate (ADC) (67)
Approvals (13700)
Artificial intelligence (192)
Autoimmune disease (13)
Automation (8)
Bankruptcy (219)
Best Places to Work (9008)
BIOSECURE Act (7)
Biosimilars (46)
Biotechnology (67)
Bladder cancer (53)
Brain cancer (21)
Breast cancer (233)
Cancer (1732)
Cardiovascular disease (121)
Career advice (898)
Career pathing (16)
CAR-T (98)
Cell therapy (284)
Cervical cancer (16)
Clinical research (50926)
Collaboration (579)
Compensation (329)
Complete response letters (9)
COVID-19 (1730)
CRISPR (19)
C-suite (175)
Cystic fibrosis (58)
Data (1774)
Decentralized trials (2)
Denatured (17)
Depression (32)
Diabetes (201)
Diagnostics (4976)
Digital health (13)
Diversity (6)
Diversity, equity & inclusion (23)
Drug discovery (72)
Drug pricing (67)
Drug shortages (21)
Duchenne muscular dystrophy (64)
Earnings (62588)
Editorial (22)
Employer branding (12)
Employer resources (75)
Events (81932)
Executive appointments (584)
FDA (14704)
Featured Employer (22)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (537)
Gene editing (54)
Generative AI (15)
Gene therapy (174)
GLP-1 (494)
Government (3348)
Grass and pollen (4)
Guidances (42)
Healthcare (15602)
Huntington's disease (15)
IgA nephropathy (19)
Immunology and inflammation (64)
Indications (22)
Infectious disease (1819)
Inflammatory bowel disease (103)
Inflation Reduction Act (6)
Influenza (33)
Intellectual property (63)
Interviews (133)
IPO (12638)
IRA (27)
Job creations (2574)
Job search strategy (808)
Kidney cancer (8)
Labor market (12)
Layoffs (252)
Leadership (12)
Legal (5128)
Liver cancer (63)
Lung cancer (248)
Lymphoma (109)
Machine learning (4)
Management (27)
Manufacturing (147)
MASH (53)
Medical device (13412)
Medtech (13416)
Mergers & acquisitions (14366)
Metabolic disorders (492)
Multiple sclerosis (59)
NASH (16)
Neurodegenerative disease (59)
Neuropsychiatric disorders (14)
Neuroscience (1396)
NextGen: Class of 2025 (5053)
Non-profit (3408)
Northern California (1979)
Now hiring (18)
Obesity (255)
Opinion (117)
Ovarian cancer (57)
Pain (70)
Pancreatic cancer (63)
Parkinson's disease (116)
Partnered (16)
Patents (133)
Patient recruitment (84)
Peanut (42)
People (47237)
Pharmaceutical (26)
Pharmacy benefit managers (12)
Phase I (15605)
Phase II (22333)
Phase III (17233)
Pipeline (943)
Policy (79)
Postmarket research (1949)
Preclinical (5944)
Press Release (69)
Prostate cancer (82)
Psychedelics (23)
Radiopharmaceuticals (209)
Rare diseases (235)
Real estate (4155)
Recruiting (28)
Regulatory (17105)
Reports (22)
Research institute (1896)
Resumes & cover letters (137)
Rett syndrome (4)
RNA editing (3)
RSV (21)
Schizophrenia (58)
Series A (87)
Series B (61)
Service/supplier (3)
Sickle cell disease (26)
Southern California (1690)
Special edition (5)
Spinal muscular atrophy (124)
Sponsored (19)
Startups (2699)
Stomach cancer (11)
Supply chain (47)
Tariffs (12)
The Weekly (11)
United States (17191)
Vaccines (411)
Venture capitalists (17)
Weight loss (159)
Women's health (20)
Worklife (5)
Date
Today (45)
Last 7 days (330)
Last 30 days (1732)
Last 365 days (25705)
2025 (7179)
2024 (27777)
2023 (32077)
2022 (41819)
2021 (44875)
2020 (43565)
2019 (37249)
2018 (28248)
2017 (25597)
2016 (24560)
2015 (29275)
2014 (22385)
2013 (18656)
2012 (19959)
2011 (20707)
2010 (19443)
Location
Africa (507)
Alabama (25)
Alaska (5)
Arizona (146)
Arkansas (11)
Asia (31366)
Australia (4868)
California (4411)
Canada (1536)
China (413)
Colorado (201)
Connecticut (207)
Delaware (121)
Europe (66362)
Florida (678)
Georgia (154)
Idaho (45)
Illinois (425)
India (18)
Indiana (254)
Iowa (3)
Japan (140)
Kansas (83)
Kentucky (20)
Louisiana (7)
Maine (65)
Maryland (732)
Massachusetts (3313)
Michigan (165)
Minnesota (337)
Mississippi (2)
Missouri (66)
Montana (27)
Nebraska (22)
Nevada (45)
New Hampshire (62)
New Jersey (1363)
New Mexico (16)
New York (1273)
North Carolina (760)
North Dakota (5)
Northern California (1979)
Ohio (148)
Oklahoma (9)
Oregon (26)
Pennsylvania (1006)
Puerto Rico (9)
Rhode Island (28)
South America (748)
South Carolina (19)
Southern California (1690)
Tennessee (85)
Texas (665)
Utah (144)
Virginia (106)
Washington D.C. (45)
Washington State (343)
West Virginia (3)
Wisconsin (47)
531,483 Results for "select medical corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Select Medical Holdings Corporation to Announce Second Quarter 2024 Results on Thursday, August 1, 2024
Select Medical Holdings Corporation, will release the financial results for its second quarter ended June 30, 2024 on Thursday, August 1, 2024 after the market closes.
June 28, 2024
·
1 min read
Business
Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2024 and Cash Dividend
Select Medical Holdings Corporation announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend.
May 2, 2024
·
25 min read
Business
Select Medical Holdings Corporation to Announce First Quarter 2024 Results on Thursday, May 2, 2024
Select Medical Holdings Corporation, will release the financial results for its first quarter ended March 31, 2024 on Thursday, May 2, 2024 after the market closes.
April 5, 2024
·
1 min read
Pharm Country
Select Medical Holdings Corporation Announces Potential Separation of Concentra
Select Medical Holdings Corporation announced that its board of directors has approved a plan to pursue the separation of Select Medical’s wholly-owned occupational health services business, Concentra Group Holdings Parent, LLC.
January 3, 2024
·
8 min read
Press Releases
Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting
February 20, 2025
·
3 min read
Press Releases
Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference
November 13, 2024
·
1 min read
BioMidwest
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
SeaStar Medical Holding Corporation announces the publication of a peer-reviewed article in NatureScientific Reports that describes the mechanism of action of the Company’s Selective Cytopheretic Device in the immunomodulation of excessive inflammation.
June 7, 2024
·
6 min read
Press Releases
FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
January 13, 2025
·
6 min read
Press Releases
OncoC4 Selected to Present at the 2025 AACR Meeting’s Showcase Session
April 16, 2025
·
2 min read
Press Releases
MOMA Therapeutics Provides Corporate Update and Announces Exclusive License Agreement for Selective PARP1 Inhibitor
January 8, 2025
·
3 min read
1 of 53,149
Next
